Point of care ultrasound cardiac examination
OtherThe study intervention consists of a POCUS cardiac examination by site approved personal using an FDA cleared US scanner. Usual care of study participants will not be impacted.
NCT Number: NCT05631977
The present study is a preparatory step towards a multi-reader multi case (MRMC) randomized fully crossed study. As POCUS images are frequently not stored and not methodically acquired using a standardized image acquisition protocol this study will collect cardiac POCUS images in a prespecified manner.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
Sheba Medical Center, Ramat Gan, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Exclusion criteria
An individual who meets any of the following criteria will be excluded from participation in this study:
The study intervention consists of a POCUS cardiac examination by site approved personal using an FDA cleared US scanner. Usual care of study participants will not be impacted.
Time frame: 1 month
Primary endpoint: Percent of POCUS exams that attain the pre-specified POCUS image quality threshold (quality standard)
Time frame: 1 month
Analysis of primary endpoint (POCUS exam quality) by the prespecified subgroups of age (above or below 65), gender, BMI group (below or above 25) and US device manufacturer.
Aisap LTD
Industry
Acronym: POCUS_ACQ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07328815
Diagnosis, Disease
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05776602
Brain Diseases, Brain Neoplasms
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT07023705
Cardiovascular Diseases, Diagnosis
Cairo, Egypt
View Trial DetailsNCT06201832
Amyloid Neuropathies, Amyloid Neuropathies, Familial
La Marsa, Tunis Governorate, Tunisia
View Trial Details